Improving management of diabetic kidney disease: will GLP-1 receptor agonists have a role?

被引：4
作者：
Bellary, Srikanth [1 ,2 ]
Tahrani, Abd A. [2 ,3 ,4 ]
Barnett, Anthony H. [2 ,3 ]
机构：
[1] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
[2] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
[3] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England
[4] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab CEDAM, Birmingham, W Midlands, England
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 11期
关键词：
LIRAGLUTIDE; OUTCOMES;
D O I：
10.1016/S2213-8587(20)30301-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：870 / 871
页数：2
相关论文
共 9 条
  • [1] Diabetic Kidney Disease Challenges, Progress, and Possibilities
    Alicic, Radica Z.
    Rooney, Michele T.
    Tuttle, Katherine R.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2017, 12 (12): : 2032 - 2045
  • [2] Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
    Gerstein, Hertzel C.
    Colhoun, Helen M.
    Dagenais, Gilles R.
    Diaz, Rafael
    Lakshmanan, Mark
    Pais, Prem
    Probstfield, Jeffrey
    Riesmeyer, Jeffrey S.
    Riddle, Matthew C.
    Ryden, Lars
    Xavier, Denis
    Atisso, Charles Messan
    Dyal, Leanne
    Hall, Stephanie
    Rao-Melacini, Purnima
    Wong, Gloria
    Avezum, Alvaro
    Basile, Jan
    Chung, Namsik
    Conget, Ignacio
    Cushman, William C.
    Franek, Edward
    Hancu, Nicolae
    Hanefeld, Markolf
    Holt, Shaun
    Jansky, Petr
    Keltai, Matyas
    Lanas, Fernando
    Leiter, Lawrence A.
    Lopez-Jaramillo, Patricio
    Cardona Munoz, Ernesto German
    Pirags, Valdis
    Pogosova, Nana
    Raubenheimer, Peter J.
    Shaw, Jonathan E.
    Sheu, Wayne H-H
    Temelkova-Kurktschiev, Theodora
    [J]. LANCET, 2019, 394 (10193) : 121 - 130
  • [3] Hinnen Deborah, 2017, Diabetes Spectr, V30, P202, DOI 10.2337/ds16-0026
  • [4] Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials
    Mann, Johannes F. E.
    Hansen, Thomas
    Idorn, Thomas
    Leiter, Lawrence A.
    Marso, Steven P.
    Rossing, Peter
    Seufert, Jochen
    Tadayon, Sayeh
    Vilsboll, Tina
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (11) : 880 - 893
  • [5] Liraglutide and Renal Outcomes in Type 2 Diabetes
    Mann, Johannes F. E.
    Orsted, David D.
    Brown-Frandsen, Kirstine
    Marso, Steven P.
    Poulter, Neil R.
    Rasmussen, Soren
    Tornoe, Karen
    Zinman, Bernard
    Buse, John B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) : 839 - 848
  • [6] Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
    Marso, Steven P.
    Daniels, Gilbert H.
    Brown-Frandsen, Kirstine
    Kristensen, Peter
    Mann, Johannes F. E.
    Nauck, Michael A.
    Nissen, Steven E.
    Pocock, Stuart
    Poulter, Neil R.
    Ravn, Lasse S.
    Steinberg, William M.
    Stockner, Mette
    Zinman, Bernard
    Bergenstal, Richard M.
    Buse, John B.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04) : 311 - 322
  • [7] Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial
    Muskiet, Marcel H. A.
    Tonneijck, Lennart
    Huang, Yao
    Liu, Minzhi
    Saremi, Aramesh
    Heerspink, Hiddoj L.
    van Raalte, Daniel H.
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2018, 6 (11) : 859 - 869
  • [8] Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
    Perkovic, V.
    Jardine, M. J.
    Neal, B.
    Bompoint, S.
    Heerspink, H. J. L.
    Charytan, D. M.
    Edwards, R.
    Agarwal, R.
    Bakris, G.
    Bull, S.
    Cannon, C. P.
    Capuano, G.
    Chu, P. -L.
    De Zeeuw, D.
    Greene, T.
    Levin, A.
    Pollock, C.
    Wheeler, D. C.
    Yavin, Y.
    Zhang, H.
    Zinman, B.
    Meininger, G.
    Brenner, B. M.
    Mahaffey, K. W.
    McGuire, Darren K.
    Holman, Rury
    Home, Philip
    Scharfstein, Dan
    Parfrey, Patrick
    Shahinfar, Shahnaz
    August, Phyllis
    Chang, Tara
    Sinha, Arjun D.
    Januzzi, James
    Kolansky, Daniel
    Amerena, John
    Hillis, Graham
    Gorelick, Philip
    Kissela, Brett
    Kasner, Scott
    Lindley, Richard
    Fulcher, Greg
    Ounadjela, Souhila
    Hufert, Karina
    von Ingersleben, Gabriele
    Gaglia, Jason
    Harris, Ronald
    Hudson, Margo
    Turchin, Alexander
    Cheifetz, Adam
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24) : 2295 - 2306
  • [9] Sodium-glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy
    Skrtic, Marko
    Cherney, David Z. I.
    [J]. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2015, 24 (01) : 96 - 103
1